Baltimore-Washington Financial Advisors’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-50
Closed -$5K 341
2013
Q3
$5K Buy
+50
New +$5K ﹤0.01% 199